Author’s Guidelines for Writing a Pharmaceutical Journal

Manuscripts preferred for publication in Scientific Journals are those which:

1. Contain original work – This is not published elsewhere in any medium by the authors or anyone else and is not under consideration for publication in any other medium. This restriction does not apply to review articles.
2. Are focused on the core aims and scope of the journal – Scientific journal publishing fundamental research results from all fields of concerned article.
3. Are clearly and correctly written – should contain all essential features of a complete scientific paper, should be written in a clear, easy to understand and be readable for a wide audience of chemists.
4. Are written in English – should be clearly and grammatically written, in an easily readable style. Attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper.

Content of Your Article Should Consist the following—

Paper Section:
1. Title page with:
1.1. Title (short title)
1.2. Name of author(s)
1.3. Name and address of workplace(s)
1.4. Personal e-mail address (es)
2. Abstract
3. Keywords
4. Text
4.1 Introduction
4.2 Results and Discussion
4.3 Materials and Methods
4.4 Conclusion
5. Reference lists

Additionally, authors are requested to prepare a graphic presentation which will provide the essence of their work. It is meant to capture reader’s attention to the articles. It may contain a key structure, reaction, equation etc that is discussed in the manuscript. Graphical abstracts will be listed along with the manuscript’s title and author’s names. Each of these elements is detailed below:

Title page

1.1. Title (short title)
We suggest the title should be relatively short but informative. If a long title is necessary, please prepare an optional short title.
1.2. Name(s) of author(s)
A list of all authors of the paper should be prepared. We need full first name, initial(s) for middle name(s) and full last name.
1.3. Name and address of workplace(s)
Authors’ affiliations should be indicated in this section. Either endnote or footnote (endnote recommended) can be used to present additional information (for example: permanent, adequate postal addresses).
1.4. Personal e-mail address(es)
At least one e-mail address is needed. It will be used as the corresponding author’s email address in all contacts with the authors.

2. Abstract

An abstract must accompany every article. It should be a brief summary of the significant items of the main paper. An abstract should give concise information about the content of the core idea of your paper. It should be informative and not only present the general scope of the paper but also indicate the main results and conclusions.

An abstract should not normally exceed 250 words. It should not contain literature citations or allusions to the tables or illustrations. All non-standard symbols and abbreviations should be defined. In combination with the title and key-words, the abstract is an indicator of the content of the paper. Authors should remember that online systems rely heavily on the content of titles and abstracts to identify articles in electronic bibliographic databases and search engines. They are therefore requested to take great care in preparing these elements.

3. Keywords

List of all keywords proposed by the authors, separated by commas. Up to 5 key terms can be selected. We would suggest avoid repeating the title.

4. Text

General rules for writing:
– use simple and declarative sentences; avoid long sentences, in which the meaning may be lost by complicated construction;
– be concise, avoid idle words;
– make your argumentation complete; use commonly understood terms; define all non-standard symbols and abbreviations when you introduce them;
– explain all acronyms and abbreviations when they first appear in the text;
– use all units consistently throughout the article;
– be self-critical as you review your drafts.

Page format: Manuscripts should be prepared as word processing documents on A4, or Letter size paper, leaving a liberal margin (2 cm) on all four sides. The manuscript should be typed double-spaced throughout (with a space of 24 points, that is, 6 mm, between lines), including references and tables. All figures and tables should be in the text and one additional copy given on a separate page.
Fonts: Serif fonts such as Times, Times New Roman, and Symbol are recommended; point size should be 12. For electronic submission, Helvetica, Courier, Palatino, Avant Garde, Bookman, and Zapf Dingbats are also supported by Adobe and ensured to create proper PDF files. The use of any other fonts, especially such as Asian, Cyrillic, and Arabic fonts, must be avoided because files containing these fonts might cause technical problems when opened or printed for reviewing.

4.1 Introduction: Present the subject of paper clearly, indicate the scope of the subject, present the goals of paper, novelty of research work and finally the organization of paper.
4.2 Results and Discussion: may be combined or kept separate and may be further divided into subsections. This section should not contain technical details. Abbreviations and acronyms should be used sparingly and consistently. Where they first appear in the text, they should be defined; authors may also explain large numbers of abbreviations and acronyms in a footnote on the first page.
4.3 Materials and Methods: Animals and chemicals should be described in the first two paragraphs. The permission from animal ethical committee should be mentioned. The source of chemicals and drugs should be given unless obviously unnecessary. The basis of dosage calculation (free form or salt used) should be indicated. Sex, strain and approximate weight of animals should be given (e.g.: “Male Wistar rats; 100–230 g…”) and housing and feeding conditions briefly described. Dosage schedules need not be mentioned in “Materials and Methods” if easily seen from graphs or tables. The route of administration (po, iv, ip, icv), solvent etc. should be indicated. Newly introduced techniques should be described in detail to allow easy repetition. Any modification should be mentioned briefly, with proper references. Techniques which have been previously described should be mentioned in brief only, with proper references, unless they were published in sources that are not easily accessible.

Experimental Part: should be written in sufficient detail to enable others to repeat the authors’ work. Chemical compounds should be named according to the systematic rules of IUPAC or Chemical Abstracts. Common trivial names that are accepted by IUPAC can also be used. Units and dimensions should be expressed according to the metric system and SI units.
Computational Part: in theoretical papers, technical details such as the computational methods, and models applied or newly developed models should be presented in an appropriately named section. Sufficient detail should be provided to enable readers to reproduce the calculations.
4.4 Conclusion: should be representing the summary of the important findings.

Footnotes/Endnotes/Acknowledgements
We encourage authors to restrict the use of footnotes. If necessary, please make endnotes rather than footnotes. Allowable footnotes/endnotes may include:
· The designation of the corresponding author of the paper;
· The current address of an author (if different from that shown in the affiliation);
· Traditional footnote content.

Information concerning research grant support should appear in a separate Acknowledgements section at the end of the paper, not in a footnote. Acknowledgements of the assistance of colleagues or similar notes of appreciation should also appear in an Acknowledgements section, not in footnotes.

Tables

Authors should use tables only to achieve concise presentation, or where the information cannot be given satisfactorily in other ways. Tables should be numbered consecutively using Arabic numerals and should be in the text itself. Each table should have an explanatory caption which should be as concise as possible.

Figures

Authors may use line diagrams and photographs to illustrate theses from their text. The figures should be clear, easy to read and of good quality. Styles and fonts should match those in the main body of the article. Lettering and lines should be of uniform density and the lines unbroken. Axis labels should be in bold face. Units should be placed next to variables in parentheses. All figures must be in the text and be numbered with Arabic numerals.

Schemes

By schemes we understand sequences of reactions. They should have brief titles describing their contents. Schemes should be numbered with Arabic numerals. Authors should insert in the main text where table/figures/schemes should be necessary.

Multimedia and images

Authors can attach files in most popular formats, including (for example): images in BMP, GIF, JPEG formats,

To help you in formatting your images (including tables and figures) or multimedia files, please submit the paper with additional separate attachments also, apart from in the text.

5. Reference list

The references should be cited in the text in large brackets not in superscript or subscript. A complete reference should give the reader enough information to find the relevant article. Please pay particular attention to spelling, capitalization and punctuation here. Completeness of references is the responsibility of the authors. A complete reference should comprise the following:

An article in a journal
Author’s Initials Surname, journal, year, volume, issue, page no.
H. Li, J. Kim, L. Groy, J. Am. Chem. Soc., 2001, 123, 4867.

A book
Author’s Initials. Surname, Title, Edition — if not the first, (Publisher, Place of publication, Year of publication).
C.N.Rao, A. Muller, A. K. Cheetham; The Chemistry on Nanomaterials. Synthesis, Properties and Applications, Wiley-Vch, Weinheim, 2004.

A part/chapter book
Author’s Initials. Surname, In: Editor’s Initials. Editor’s Surname (Ed.), Book Title, Edition — if not the first, (Publisher, Place of publication, Year of publication) page number.
C.K. Clenshaw, K. Lord, In: B.K. P. Scaife (Ed.), Studies in Numerical Analysis (Academic Press, London and New York, 1974) 95.

A conference proceeding
Author’s Initials. Surname, In: Editor’s Initials. Editor’s Surname (Ed.), Conference, date, place (town and country) of conference (Publisher, place of publication, year of publication) page number.
A. Kaczanowski, K. Malarz, K. Kulakowski, In: T.E. Simos (Ed.), International Conference of Computational Methods in Science and Engineering, 12-16 Sep. 2003, Kastoria, Greece (World Scientific, Singapore 2003) 258.

A thesis
Author’s Initials. Surname, DSc/PhD/MSc/BSc thesis, University, (town, country, year of publication).
A.J. Agutter, PhD thesis, Edinburgh University (Edinburgh, UK, 1995).

An article in a newspaper
Author’s Initials. Surname, Newspaper Title, date of publication, page number.
A. Sherwin, The Times, 13 Jul. 2007, 1.

Patents
Patents:  A. B. Inventor1, C. D. Inventor2, (Holder), Country Code and patent number (registration year).

GenBank/DNA sequence linking
Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see example below.) This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add the required link to GenBank’s sequences.

Example: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).

Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article, the accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.

Software
Software used as part of computer-aided drug/agent design (e.g., molecular modeling, QSAR, conformational analysis, molecular dynamics) should be readily available from accepted sources and the authors may specify where the software can be obtained. Assurance of the quality of the parameters employed for the relevant potential functions should be detailed in the manuscript.
Before submitting your article, please ensure you have checked your paper for any relevant references you may have missed. You should make sure the information is correct so that the linking reference service may link abstracts electronically.

Nomenclature, Symbols, Units and expressions in Latin
For correct expression of quantities, units and symbols please refer to IUPAC recommendations available at www.iupac.org.

Submission formats
Manuscripts for Journals can be submitted in the following formats:
·  MS Word (97 or higher) either as standard DOCUMENT (.doc) or RICH TEXT
FORMAT (.rtf) or PDF.
·  .JPG, .TIFF or .EPS can be used for graphical abstract

Watch the video related to nanomaterials

Staff from Brookhaven’s new Center for Functional Nanomaterials (CFN) describe how this advanced facility will focus on the development and understanding of nanoscale materials. The CFN provides state-of-the-art capabilities for the fabrication and study of nanoscale materials, with an emphasis on atomic-level tailoring to achieve desired properties and functions. The overarching scientific theme of the CFN is the development and understanding of nanoscale materials that address the Nation’s …

Help answer the question about nanomaterials

Can someone explain to me what nanomaterials are?
how they're created etc. just a brief overview of the processes involved and thinking behind it would do, im in a chemical engineering class through my school but im a mechanical engineering major so i dont think ill be able to take further courses in this area because of my strict schedule for when i have to take what. and since im really interested in the topic i thought id ask

About Author

This article is written by one of the editors of Der Pharma Chemica, A Journal for Medicinal Chemistry,Pharmaceutical Chemistry and Computational Chemistry.For knowing more Please visit the website http://derpharmachemica.com/